Home
About
Company
Organization
History
Team
Honor
Culture
Concept
Responsibility
Memoir
Video
News
Company notice
Company news
Media coverage
Innovation
Quality
HSE
Product
Halobios
Preparation
Raw material
Chinese Medicine
Health Products
Medical instrument
Service
Contact
Network
Stock code
603811
CN
Stock code
603811
Home
News
Company notice
Company notice
2024,04,27
Joint drugs have seen steady growth in revenue for many years, and fish oil health products have emerged as a rising star. Securities Times
2024,04,27
Realize a net profit of 163 million yuan in 2023 and adhere to a high proportion of dividends to give back to investors
2024,04,21
Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors
Cheng Yi
Company notice
Company news
Media coverage
2022,12,20
Announcement on the List of "Most Beautiful Factories" in Wenzhou City in 2022
2022,10,26
Wenzhou Science and Technology Plan Project Acceptance Publicity
2022,09,21
Dongtou Newly Added 3 Provincial Key Projects
2022,08,25
Cheng Yi Pharmaceutical Fish Oil Soft Capsule Obtained Food Production License
2022,03,28
Cheng Yi won the 2021 Wenzhou City Mayor's Quality Award
2021,03,18
Cheng Yi awarded title of "Advanced Collective for Promoting High Quality Development in Wenzhou"
2021,02,25
Cheng Yi Pharmaceutical was awarded the "Most Beautiful Factory" in Wenzhou
2020,04,30
Cheng Yi Pharmaceutical Drug Conformity Evaluation through Generic Drugs
2020,03,18
Cheng Yi's "Marine Biomedical Manufacturing Project" has been put into operation
2020,02,05
Ribavirin was selected into the diagnosis and treatment scheme of COVID-19
2019,10,21
Sincere Pharmaceutical won the "Best Growth Potential Listed Company" award
2018,07,09
Tender Announcement for the Interior Decoration Design and Construction Project of the R&D Building of Chengyi Pharmaceutical Health Industrial Park
<
1
2
>
Contact Us
view more